Memantine for the Treatment of Dementia: A Review on its Current and Future Applications

Cited by (247)

Items 201–247 of 247

1. Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders
   Snježana Radulović, Sowmya Sunkara, Christa Maurer, Gerd Leitinger · 2021 · International Journal of Molecular Sciences
2. ESTIMATING THE EFFECTS OF Z-DRUGS ON THE RISK OF COGNITIVE IMPAIRMENT
   Xuan Zhang · 2018 · UKnowledge (University of Kentucky)
3. Investigation of the intercellular transmission of α-synuclein, amyloid-β and TDP-43
   Christopher Sackmann · 2019 · Linköping University medical dissertations
4. The Propagation of Neurodegenerative Diseases by Inflammation and Exosomes
   Valerie Sackmann · 2019 · Linköping University medical dissertations
5. Management of the predementia stage of Alzheimer’s disease, complicated with hypoactive delirium
   О. Н. Ткачева, M. A. Cherdak, Elen A. Mkhitaryan · 2021 · Russian neurological Journal
6. Long Noncoding RNA Expression Profiles of Rat Extrasynaptic and Synaptic Neurons Expressing the N-methyl-D-Aspartate Receptor Revealed by Microarray Analysis
   Huan Wang, Shunze Hu, Shutao Gao, Kun Chen, Xuying Sun, Huang Fang · 2021 · World Neurosurgery
7. Assembling an understanding: the critical role of SARS-CoV-2 envelope and membrane proteins in virion formation
   Sara Kowalski · 2026 · Open Collections
8. Effect of Memantine on Prolonging Safe Driving in Early AD: a Pilot Study
   Peter J. Holland, Ruth Marchand Tappen, David O. Newman, Katherine Freeman-Costin, Lori J. Fisher · 2021 · Canadian Geriatrics Journal
9. Síntese e avaliação da citotoxicidade de chalconas e derivados com efeito inibitório sobre acetilcolinesterase e beta-secretase (BACE-1)ß
   Giorgio Antoniolli · 2018
10. Memantine for Treatment of Dementia
    Thomas H. Müller, Wilfried Kuhn · 2022 · Springer eBooks
11. New directions of research in the pharmacotherapy of Alzheimer’s disease
    Lucia Ţurcan, Anastasia Caracaş, Dumitru Stirba, Svelana Latus, Olesea Malancea, Nicolae Bacinschi · 2022 · Bulletin of the Academy of Sciences of Moldova Medical Sciences
12. Therapeutic role of memantine for the prevention of cognitive decline in cancer patients with brain metastasis receiving whole-brain radiotherapy: a narrative review
    Melmar Cerilo Folloso, Mazelle Torres, Stephen Lowell Ciocon, Jed Noel Ong, Jerickson Abbie Flores, Joseree-Ann S Catindig · 2022 · Dementia & Neuropsychologia
13. Cannabinoid-basierte Therapie in einem Modell für die sporadische Alzheimer-Erkrankung
    Marius E. Sichler · 2022 · eDiss (Georg-August-Universität Göttingen)
14. Safety and Efficacy of Memantine in Improving Cognitive Function of Patients with Epilepsy
    Pargol Balali, Seyedeh Sajedeh Marashi, Elmira Agah, Mahdi Shafiee Sabet, Nasrin Rahimian, Sajad Shafiee, Vajiheh Aghamollaii, Abbas Tafakhori · 2022 · Caspian Journal of Neurological Sciences
15. Chronic pain management in the home setting
    Lynn Hendrix, Eve Harrison · 2022 · Elsevier eBooks
16. Memantine for Treatment of Dementia
    Thomas H. Müller, Wilfried Kuhn · 2022 · Springer eBooks
17. The effects of Memantine and MK801 on NMDA receptor switching 2B and 2A subunits in hippocampal cell culture.
    Ezequiel Uribe, Eduardo H. Sánchez-Mendoza · 2022 · Archivos de Neurociencias
18. Design, Synthesis, and Neurotrophic Effect of Arg-Glu-Arg-Met-Ser-(3,5)-Dimethyladamantan-1-Amine In Vitro Evaluations as a Potential NMDAR Antagonist
    Xiaozhen Wang, Ze Li, Xiaoyi Zhang, Meimei Kang, Caizhen Lv, Xu Zhang, Zhiwei Zhao, Yanchuan Wu, Penghui Song, Rong Wang · 2023 · Journal of Chemistry
19. Complexos metálicos de Ag(I) e Pt(II) com aminoadamantanos
    Anna Karla dos Santos Pereira · 2021
20. Perspectivas atuais da doença de Alzheimer: aspectos patogênicos e terapêuticos
    Ray de Lima Coutinho Costa, Martha de Araujo Medeiros Pereira, Letícia Cantuária Santana, Alexandre Santos Lima, Luis Guilherme Gomes de Athayde, Natália Caminha Freire de Albuquerque, Alina Malta Brandão Nunes, Alícia Malta Brandão Nunes, Paulo Vytor Cardoso Nobre, Antônio Carlos Ramos Valença Neto et al. · 2024 · Brazilian Journal of Implantology and Health Sciences
21. Unveiling Alzheimer's
    S. H. Annie Silviya, T. Sunitha, C. M. Hilda Jerlin, Nithya Sampath, P. Thiruselvan · 2024 · Advances in bioinformatics and biomedical engineering book series
22. Pharmacotherapy of Alzheimer's disease: A thorny road to success
    Nurul Husna Ibrahim, Jaya Kumar, Wael M.Y. Mohamed · 2024 · Elsevier eBooks
23. Effects of CAPAH, memantine, and rivastigmine on behavioral and cognitive functions of rats
    Никитин Дмитрий Олегович, Сёмина Ирина Ивановна, Валеева Елена Валерьевна, Anastasiya V. Nikitina, Ajgul Z. Hafizova, A. G. Ovchinnikova · 2024 · Pharmacokinetics and Pharmacodynamics
24. Cardiovascular Effect of Drugs Used to Treat Alzheimer’s Disease
    Shirley Eng, Esewi Aifuwa, William H. Frishman, Wilbert S. Aronow · 2024 · Cardiology in Review
25. Skin Lesions as Signs of Neuroenhancement in Sport
    S A Popescu, Roman Popescu, Vlad Mihai Voiculescu, Carolina Negrei · 2025 · Brain Sciences
26. Clinical trials
    Sarah Gregory, Stina Saunders, Craig William Ritchie · 2025 · Elsevier eBooks
27. Phosphodiesterase‑5 inhibitors and Alzheimer’s disease; a meta‑analysis on clinical studies
    Saman Behboodi Tanourlouee, Parham Torabinavid, Ali Vaezi, Mina Ghorbanpour, Mir Saeed Yekaninejad, Erfan Amini, Masoud Bitaraf · 2025 · npj Dementia
28. Could memantine be a treatment option for ADHD and ASD?
    Aleksandra Suchołbiak, Oskar Mikołajczyk, Magdalena Flaga-Łuczkiewicz · 2025 · Psychiatria i Psychologia Kliniczna
29. Pharmacoepigenetics of memantine in dementia and related considerations in SARS-CoV-2 virulence
    Yıldız Dinçer, Andleeb Shahzadi, İlhan Onaran · 2025 · Elsevier eBooks
30. Assessing the Efficacy of Cognitive Enhancers in Electroconvulsive Therapy: A Randomized Controlled Trial of Rivastigmine and Memantine
    Parniyan Molaee, Nafiseh Jahangiri Zarkani, Maria Tavakoli Ardakani, Seyedeh Morvarid Neishabouri, Fateme Kazemi Khaledi, Alireza Shamsi · 2025 · Clinical Neuropharmacology
31. EFFECTIVENESS OF LECANEMAB AND DONANEMAB TREATMENT FOR EARLY ALZHEIMER’S DISEASE
    Maria Ufniarska, Tomasz Ufniarski, Aleksandra Piech, Karolina Pasierb, Karol Poplicha, Martyna Grodzińska, Bartłomiej Siuzdak, Justyna Moszkowicz, Piotr Sobkiewicz, Patrycja Kardasz et al. · 2025 · International Journal of Innovative Technologies in Social Science
32. Cyanidin-3-O-galactoside attenuates Aβ aggregation and disintegrates preformed amyloid fibril
    Boyu Xie, Rui Ping Xu, Jia Fu, PeiAo Zhang, Zhongxin Liang, Jun Zheng, Miaoshu Wang, Haichao Wen, Dong Joo Yang · 2025 · Phytomedicine Plus
33. Receptor targets in Alzheimer's disease drug discovery
    Branden Stanley, Jason V. Wallach, Adeboye Adejare · 2025 · Elsevier eBooks
34. Additional file 1 of Effect of policosanol from insect wax on amyloid β-peptide-induced toxicity in a transgenic Caenorhabditis elegans model of Alzheimer’s disease
    Zhang, Xin, Chenjing Ma, Sun, Long, He, Zhao, Feng, Ying, Li, Xian, Gan, Jin, Chen, Xiaoming · 2021 · Figshare
35. Research Progress on the Antagonism of Aluminum‐Induced Neurotoxicity by Ginsenosides
    Lu Zhihang, Lu Jiaxu, Ye Zhao, Feng Zhuonan, Yin BaiShuang, Zhu Yanzhu · 2026 · Cell Biology International
36. Nanocarriers in Alzheimer’s Therapy: A Comprehensive Review on Nanoparticulate Drug Delivery Systems
    Ashish Kumar Parashar, Gaurav Kant Saraogi, Vandana Arora Sethi, Haya Khader Ahmad Yasin · 2026 · Current Neurovascular Research
37. Computational strategies for drug discovery in neurodegeneration: Targeting Alzheimer’s and Parkinson’s disease
    Ayoub Ben-Hadda, Fatimazahra Guerguer, Meriem Khedraoui, Imane Yamari, Samir Chtita · 2026 · Letters in Drug Design & Discovery
38. A Study of 3-Substituted 7-Methoxy-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ols Leading to Candidate PET Radioligands for Imaging Brain GluN2B: Design, Synthesis, and Structure–Activity Relationships
    Lisheng Cai, Leah Millard, Sean W. Costner, Alyssa Wang, Yonglan Liu, Victor William Pike · 2026 · Molecules
39. Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer’s Disease: A Systematic Review
    S. Brimson, Premrutai Thitilertdecha, K. Kumaree, J. Brimson · 2026 · CNS Drugs
40. Rational drug design for Alzheimer’s disease: from approved therapies to next-generation clinical candidates and AI-guided innovation
    Sana Saffour, Turgut Seçkin Gül, Halise Inci Gul · 2026 · Future Medicinal Chemistry
41. Nanoscale localisation of memantine governs structural modulation and loading in bicontinuous cubic phase systems
    Lucrezia Guarneri, Raymond C. Beh, Liliana de Campo, Andrew E. Whitten, Michael Moir, Andrew Hung, Andrew J. Clulow, Charlotte E. Conn, Leonie van ‘t Hag · 2026 · Journal of Colloid and Interface Science
42. Calcium dysregulation in neurovascular function in Alzheimer’s disease: mechanisms, therapeutic targets
    Yvan D. Hanscom-Trofy, Andrew Gregory, Gilbert Charles Morgan, Hongwei Yu, Rui Dong, Fan Fan · 2026 · GeroScience
43. Aildenafil citrate with superior PDE5 selectivity ameliorates cognitive and behavioral impairments in APP/PS1 Alzheimer’s disease mice: a preclinical phenotypic study
    Shaowei Han, Fang Liu, Dawei Wang, Gengshen Song · 2026 · Frontiers in Pharmacology
44. Mechanisms of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive–Compulsive Disorder: Cortico-Striatal Circuitry, Glutamatergic Dysregulation, and Neuroplastic Constraints
    Abdullah Faisal Albukhari · 2026 · Molecular Neurobiology
45. To Study the Effect of Nilotinib, a Tyrosine Kinase Inhibitor, on Learning and Memory and Its Comparison with Nitric Oxide Synthase Inhibitor in an Animal Model of Alzheimer’s Disease
    Anurag Kumar, Nasreen Fatima, Pramod Kumar, Rajendra Nath, Amod Kumar Sachan, Rakesh Dixit, Rishi Pal · 2026 · Annals of Neurosciences
46. BindingDB Entry 50008061: Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.
    BindingDB · 2021 · UC San Diego
47. BindingDB Entry 50006695: A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.
    BindingDB · 2021 · UC San Diego